Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-23 4:25 pm Purchase | 2026-03-19 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | RA Capital Management, L.P. | 7,311,225 9.900% | 2,144,801 (+41.51%) | Filing History |
| 2026-03-11 4:43 pm Purchase | 2026-03-09 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | RA Capital Management, L.P. | 5,166,424 9.900% | 764,924 (+17.38%) | Filing History |
| 2026-02-17 4:23 pm Sale | 2025-12-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | BIOTECHNOLOGY VALUE FUND L P | 4,761,906 9.100% | -405,712 (-7.85%) | Filing History |
| 2026-02-17 08:47 am Purchase | 2025-12-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | RTW INVESTMENTS LP | 1,587,302 3.200% | 562,967 (+54.96%) | Filing History |
| 2026-01-22 4:34 pm Purchase | 2026-01-14 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Perceptive Advisors LLC | 3,471,861 7.300% | 3,471,861 (New Position) | Filing History |
| 2025-11-14 4:24 pm Purchase | 2025-09-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | BIOTECHNOLOGY VALUE FUND L P | 5,167,618 9.990% | 4,249,790 (+463.03%) | Filing History |
| 2025-11-14 4:18 pm Purchase | 2025-09-30 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Woodline Partners LP | 7,125,881 9.900% | 7,125,881 (New Position) | Filing History |
| 2025-10-03 4:30 pm Purchase | 2025-09-29 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Vivo Opportunity Fund Holdings, L.P. | 25,931,000 9.990% | 25,931,000 (New Position) | Filing History |
| 2025-10-03 4:26 pm Purchase | 2025-09-26 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | RA Capital Management, L.P. | 4,401,500 9.900% | 4,401,500 (New Position) | Filing History |
| 2025-10-03 4:05 pm Purchase | 2025-09-26 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Commodore Capital LP | 4,522,977 9.900% | 2,691,231 (+146.92%) | Filing History |
| 2025-02-14 09:00 am Sale | 2024-12-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | RTW INVESTMENTS LP | 1,024,335 9.990% | -8,196,337 (-88.89%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Commodore Capital LP | 1,831,746 3.500% | 1,138,500 (+164.23%) | Filing History |
| 2024-02-14 07:02 am Purchase | 2023-12-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | RTW INVESTMENTS LP | 9,220,672 9.990% | 9,220,672 (New Position) | Filing History |
| 2024-02-14 06:28 am Sale | 2023-12-31 | 13G | SAB BIOTHERAPEUTICS INC SABS | Radcliffe Capital Management L.P. | 0 0.000% | -62,756 (Position Closed) | Filing History |
| 2023-12-04 4:33 pm Purchase | 2023-11-22 | 13G | SAB BIOTHERAPEUTICS INC SABS | BIOTECHNOLOGY VALUE FUND L P | 917,828 9.990% | 917,828 (New Position) | Filing History |
| 2023-10-16 4:05 pm Purchase | 2023-10-04 | 13G | SAB BIOTHERAPEUTICS INC SABS | Commodore Capital LP | 693,246 9.900% | 693,246 (New Position) | Filing History |
| 2022-12-16 4:33 pm Purchase | 2022-12-07 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | HAMILTON CHRISTINE E | 871,205 17.300% | 9,881 (+1.15%) | Filing History |
| 2022-09-08 5:07 pm Purchase | 2022-09-07 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | Sullivan Eddie Joe | 571,911 13.300% | 1,400 (+0.25%) | Filing History |
| 2022-09-08 5:04 pm Sale | 2022-06-07 | 13D | SAB BIOTHERAPEUTICS INC NE SABS | HAMILTON CHRISTINE E | 861,324 20.000% | -207,274 (-19.40%) | Filing History |
| 2022-05-27 4:24 pm Sale | 2022-05-20 | 13D | SAB BIOTHERAPEUTICS INC SABS | Big Cypress Holdings LLC | 96,530 2.200% | -208,403 (-68.34%) | Filing History |